Presence of lung metastases in bitches affected by malignant mammary neoplasms in Medellin (Colombia) by Gómez J, Brigitte et al.
2983
Presence of lung metastases in bitches affected by 
malignant mammary neoplasms in Medellin (Colombia)
Presencia de tumores mamarios malignos con metástasis a 
pulmón en perras en Medellín (Colombia)
Brigitte Gómez J,1 M.Sc, María Ramírez R,1,2 M.Sc, Juan Maldonado E,1* Ph.D.
Universidad de Antioquia, Facultad de Ciencias Agrarias, Escuela de Medicina Veterinaria,  1Grupo Centauro, 
2Grupo Quirón. Medellín, Colombia. *Correspondence: juanguimal@gmail.com
Recibido: Mayo de 2011; Aceptado: Enero de 2012.
ABSTRACT
Objectives. To define the presence of lung metastasis in bitches with malignant mammary 
neoplasms. Material and methods. Thirty female dogs that were attended at Veterinary Hospital 
(University of Antioquia, Medellin, Colombia) were selected for the study. At consultation clinical 
variables and grade of mammary and inguinal lymph node compromise were registered. Latero-
lateral and ventral-dorsal radiographic images of thorax were done for identification of radiographic 
lesions suggestive of lung metastasis. At surgery biopsies of affected mammary glands were taken 
for histopathological study and classification of tumors. Data were analyzed by descriptive statistics. 
Results. The average (± standard error) age at clinical diagnosis was 10.87±2.65 year old. French 
poodle (46.6%) cross-breed (13.3%) and Schnauzer (10%) were the breeds most frequently affected 
by mammary tumors. The most frequent tumor found was carcinoma (81%), followed by adenoma 
(8.1%), and other types (10.8%). The most frequently affected mammary glands by tumors were 
the right and the left inguinal glands (70% and 66.6%, respectively). Five out of 30 bitches (16.6%) 
had lung metastasis according to radiographic examination. From this group of dogs, 4 out of 5 
neoplasms (80%) were diagnosed as complex carcinoma by histopathology diagnosis. Conclusions. 
We provide evidence suggesting that complex carcinoma is the most frequent mammary tumor in 
bitches in our city and it is highly related to lung metastasis.. 
Key words: Canine complex carcinoma, canine mammary adenoma, canine cammary carcinoma, 
canine cammary neoplams, lung metastasis (Source:MeSH). 
RESUMEN
Objetivos. Definir la presencia de metástasis pulmonar en perras con tumores mamarios. Materiales 
y métodos. En una muestra de 30 perras atendidas en el Hospital Veterinario de la Universidad de 
Antioquia (Medellín, Colombia) con diagnóstico de tumores mamarios, al momento de la consulta, 
fueron registrados las variables clínicas y el grado de compromiso de las glándulas mamarias y de 
los nódulos linfáticos. Imágenes radiográficas latero-laterales y ventro-dorsales del tórax fueron 
tomadas para la identificación de hallazgos radiográficos compatibles con metástasis pulmonar. 
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Biopsias mamarias afectadas fueron sometidas a estudio histopatológico y clasificación del tipo de 
tumor. Los datos fueron analizados mediante estadística descriptiva. Resultados. La edad promedio 
(± error estándar) al diagnóstico clínico fue 10.87 ± 2.65 años de edad. La raza más frecuentemente 
afectada fue la French poodle (46.6%) seguida de perros cruzados (13.3%) y Schnauzer (10%). 
El carcinoma fue el tumor más hallado (81%) seguido del adenoma (8.1%) y otros tipos de tumor 
(10.8%). Las glándulas mamarias más afectadas fueron las inguinales derecha (70%) e izquierda 
(66.6%). Cinco de las 30 pacientes (16.6%), presentaron metástasis a pulmón. Entre estas, 4 de 
5 (80%) tenían carcinoma complejo. Conclusiones. El carcinoma complejo fue la neoplasia más 
frecuente y es el tipo más relacionado con metástasis pulmonar. 
Palabras clave: Adenoma mamario canino, carcinoma complejo canino, metástasis pulmonar, 
neoplasia mamaria canina (Fuente:MeSH).
INTRODUCTION 
Mammary tumors are one of the most frequently 
diagnosed neoplasms in bitches, exhibiting 
a high incidence of malignancy and a high 
metastasis degree affecting several other tissues 
(1,2). In addition, they accounts for almost 
50% of neoplasm in bitches. The average age 
at the first clinical evidence is 10 years old, 
with no predilection for the breed of the bitch 
(3,4). Canine mammary tumors have a complex 
pathogenesis, including susceptibility of bitches 
to their own endogenous sexual steroids (3,5,6), 
environmental contaminants to which dogs are 
commonly exposed such as allethrin, cyhalothrin, 
cypermethrin, deltamethrin and tetramethrin 
(7), and diet and hormonal components related 
to obesity (6).
Malignant canine mammary tumors (MCMT) 
are characterized for presenting an aggressive 
inflammatory pattern, particularly in the case of 
carcinoma, it behave as highly aggressive and 
have a low survival rate. MCMT exhibit unlimited 
growing capability, and are capable to infiltrate 
regional lymph drainage and nodes and to cause 
metastases to other tissues (8). Several studies 
have reported the incidence of canine mammary 
tumors: In a report in which 672 Beagle 
bitches were evaluated, authors found a 71% 
frequency of mammary tumors, 19% of these 
were carcinoma and most of the dogs showed a 
high frequency of metastasis (2). Radiographic 
evidence of lung metastasis was found in 14 
out of 37 bitches having malignant mammary 
tumors (carcinosarcoma, complex carcinoma, 
and simple carcinoma) (4). In Colombia, a 
retrospective study comprising the casuistic of 30 
years (1968-1998) performed in the Veterinary 
Pathology Service at University of Antioquia 
(n = 232 samples), revealed the presence of 
carcinoma in 58.6%, benign mammary tumor 
in 23.7%, mixed malignant tumor in 9.5%, and 
other type of tumors in 8.2% of the cases (9). 
However, in this study no data was reported on 
the incidence and frequency of lung metastases. 
Lymph drainage is considered as one of the most 
important route for dissemination of mammary 
tumor metastasis in dogs. Canine tumors that 
induce formation of new lymph vessel have a 
higher metastasis potential (10). Because lung 
metastasis are responsible for 25% to 50% 
of total MCMT metastasis (11), it is important 
to perform radiographic evaluation of bitches 
suffering from MCMT on a routine basis, as well 
as cytologic evaluation by fine needle puncture 
(12) and evaluation of hepato-renal function. 
When a non-cavitary interstitial lung pattern at 
radiography is observed in bitches suffering from 
MCMT, it would probably reflect the presence 
of lung metastasis which originated from 
mammary tumors (4). Accordingly, the clinical 
prognosis for bitches affected by mammary 
tumors will depend on the histological pattern of 
the tumor they suffers, as well as its infiltrating 
and metastatic capability, characteristics that 
must be determined by an accurate clinical 
exam combined with a radiological and 
histopathological diagnosis. It is also important 
to consider assessment of the estrogen and 
progesterone receptor expression (13). This 
approach could help to define the most precise 
treatment for the bitch when considering 
survival probabilities and prognosis of her 
life quality. Because studies on the frequency 
of MCMT with lung metastasis have not been 
reported in Colombia, the main objective of this 
work was to establish the frequency of lung 
metastases and the type of histological pattern/
classification of MCMT.  
MATERIALS AND METHODS 
Type of study and sample. A prospective 
descriptive pilot study was performed in which 
the records from Veterinary Hospital at University 
of Antioquia (Medellín, Colombia) were evaluated 
to define the frequency of malignant canine 
mammary tumors. Tumor samples from patients 
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included in the study were obtained only by 
previous informed consent of the dog owner. Dogs 
were subjected to surgical procedures according to 
routinary protocols for ovariohysterectomy (OH) 
and/or surgical excision of mammary tumors. 
For the study, data from 30 patients presenting 
mammary gland neoplasms at consultation were 
recorded during a 10 month period (June 2008 to 
April 2009). The group of bitches included in the 
study were pure or cross-breed females ranging 
from 7 to 18 years old. 
Inclusion criteria. Inclusion criteria of the 
study were: clinically evident nodes located in 
mammary glands, with or without compromise 
of the corresponding inguinal lymph node, and 
the availability of histopathological exam of a 
mammary node sample, and a latero-lateral and 
ventral-dorsal radiography of thorax. The only 
exclusion criteria were if the bitch was receiving 
any kind of chemotherapy schedule at the time of 
clinical diagnosis of mammary gland tumors. 
Clinical exam. At clinical examination all the 
patients were evaluated by palpation to confirm 
the presence of nodes in mammary glands, if 
there were left and/or right axillary lymph nodes 
compromise, left and/or right inguinal superficial 
lymph node compromise, and/or deep lymph 
nodes compromise. Similarly, size of the node and 
its adherence to the surrounding tissues were also 
evaluated. Then, depending if the type of tumor 
diagnosed was related to malignancy (14), bitches 
were subjected to a radiographic evaluation of 
thorax for estimation of the risk of metastasis. 
When a radiographic evidence of lung metastases 
was found, the dog was not subjected to surgical 
excision of mammary tumors. Otherwise, a post-
mortem examination was performed if the dog 
were died. On the contrary, when the diagnosis 
was negative for lung metastases, pre-surgical 
laboratory exams were performed (including 
Hemogram, alanine aminotransferase, Creatinin, 
Protrombine, Tromboplastine Partial Time) for 
defining the clinical status of the dog previous 
to its programming for surgical excision of the 
tumors (2). 
Surgical and histopathology procedures. 
Excision of the affected mammary glands was 
performed only in bitches that met the standard 
criteria for surgical procedures, according to the 
surgical protocol for excision of canine mammary 
neoplasms at “Hospital Veterinario, Universidad de 
Antioquia”. From each lymph node obtained after 
surgical excision a piece of 0.5 cm3 was taken, and 
samples were fixed in 10% formaldehyde. Fixed 
samples were processed for histopathology and 
Hematoxilin-Eosin staining performed evaluation 
under routine procedures at “Laboratorio de 
Patología Animal, Universidad de Antioquia”, 
according to the method by Misdorp et al (15). 
Samples were double-blind analyzed by a trained 
histopathologist.
Statistical analysis. Data from quantitative 
variables of patients included in the study were 
analyzed by descriptive statistics. Qualitative 
variables were compared as percentage for each 
clinical and epidemiological parameter, as well as 
for histopathological classification of the tumor 
and radiographic findings. The compromise of 
each set of lymph node-draining of mammary 
glands and localization of affected lymph nodes 
were evaluated as percentages.
RESULTS 
The most relevant clinical and epidemiological 
data of patients included in the study are 
presented in table 1. The average age at 
consultation when the bitch was detected 
having mammary gland nodes was 10.87±2.65 
year (Table 1). Poodle dogs were the genetic 
predominant group 46.66% (14/30), followed by 
13,3% cross-breed (4/30), and 10% Schnauzer 
(3/30) (Figure 1). At clinical exam 70% of the 
patients had at least three mammary glands 
Breed n % Age (years)
Overall clinical 
diagnosis
Overall 30 100 10.87 Complex carcinoma.
French poodle 14 46.66 10.57 Complex carcinoma.
Cross-breed 4 13.33 11.5
Complex carcinoma, 
tubular carcinoma, 
carcinosarcoma.
Schnauzer 3 10 12 Complex carcinoma.
Others 9 29.97 10.66 Complex carcinoma, simple carcinoma.
Table 1. Clinical and epidemiological data of patients 
included in the study.
Figure 1. Frequency distribution of malignant canine 
mammary tumors in a sample of bitches in 
Medellín (Colombia).
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with clinical evidence of tumor, whereas 16.6% 
and 13.3% had one or two affected mammary 
glands, respectively. 
Most of the bitches had compromise of the 
inguinal mammary gland: 17 out of 30 (56.6%) 
presented compromise of the right inguinal 
mammary gland, and 19 out of 30 (63.3%) 
presented compromise of the left inguinal 
mammary gland. The remaining affected 
mammary glands were as follows: 21 out of 30 
(70%) the right abdominal 2 mammary gland, 
and 20 out of 31 (66.6%) the left abdominal 2 
mammary gland, 5 out of 30 (16.66%) the right 
abdominal 1, and 7 out of 30 (23.33%) the left 
abdominal 1, 10 out of 31 (33.33%) the thoracic 
right 1, 6 out of 30 (20%) the thoracic left 1, 8 
out of 30 (26.66%), the thoracic right 2, and 9 
out of 30 (30%) the thoracic left 2 (Figure 2). 
were found in mammary nodes in the present 
study were as follows: carcinoma (81%), 
adenoma (8.1%), and fibrosarcoma (2.7%). Less 
frequently were mixed tumor, reactive lymphoid 
hyperplasia, and inflammatory. (Figure 3). 
Figure 2. Frequency of lymph node compromise in 
bitches affected by mammary tumors in 
Medellín (Colombia). T1d: right 1 thoracic, 
T2i: left 2 thoracic, T2d: right 2 thoracic, 
T2i: left 2 thoracic, A1d: right abdominal, 
A1i: left abdominal, A2d: right 1 inguinal, 
A2i: left 1 inguinal, I2d: right 2 inguinal, 
I2i: left 2 inguinal.
Nine out of 30 patients showed clinical compromise 
of the lymph nodes (30%), in 4 out of 30 patients 
(13.33%) there was compromise of a single lymph 
node, whereas in 6 out of 30 (16.66%) there was 
compromise of at least two lymph nodes. The 
most frequently affected lymph nodes according 
to the clinical finding were as follows: popliteal 
right (16.6%), inguinal left (13.3%), inguinal right 
(10%), popliteal left (10%) and pre-escapular 
right (3.33%) (Figure 2).
The prescapular left lymph node and axillary right 
lymph node were never found clinically affected. 
The most frequent histopathology patterns that 
81% (24)
8.1% (2)
2.7% (1)
2.7% (1)
2.7% (1) 2.7% (1)
Carcinoma
Adenoma
Hyperplasia
Inflammation
Fibrosarcoma
Mixed tumor
Figure 3. Number and percent distribution of canine 
mammary neoplasms according to the 
histopathological classification of the tumor.
Figure 4. Complex carcinoma characterized by epithelial 
(Arrow) and mioepithelial (Arrowhead) cells. 
H&E, 200X.
Furthermore, carcinomas were classified as 
complex carcinoma (43.2%) (Figures 4 and 5), 
simple carcinoma (13.5%), tubular carcinoma 
(8.1%) (Figures 6 and 7), carcinosarcoma 5.4%, 
lipid-rich carcinoma (2.7%), and solid carcinoma 
(2.7%). In addition, most of the patients had 
only one type of histopathological diagnosis 
(80%), whereas 16.66% and 3.33% had two 
or three types of histopathological diagnosis, 
respectively. Finally, the percentage of lung 
metastasis that was diagnosed according to 
radiographic evaluation was 16.66% (5/30). 
In this group of dogs with lung metastases the 
histopathological diagnosis for mammary gland 
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nodes were carcinoma in all patients, from 
which 80% were complex carcinomas (Figures 
4 and 5) and the remaining 20% were tubular 
carcinoma (Figure 6). 
DISCUSSION
According to our knowledge in this study for the 
first time in Colombia the association between 
malignant canine mammary tumors (complex 
carcinoma) and lung metastasis is evidenced 
by clinical, histopathological and radiographic 
data. In addition, a 30% and 16.6% frequency 
of lymph node compromise and lung metastasis, 
respectively, was established in bitches affected 
by MCMT. 
Because this study was a prospective descriptive 
pilot study, caution should be taken when 
considering the inference of our data in the 
general population of dogs in our city. According 
to the available scientific literature, it represents 
the first approach to describe the frequency of 
lung metastases in bitches affected by MCMT 
in our country. The highest frequency of Poodle 
dogs in this study should be a consequence of 
the predominance of this breed in our city rather 
than breed specific susceptibility.
Data of histopathological records of samples 
submitted to the Service of Veterinary Pathology 
at the School of Veterinary Medicine (University of 
Antioquia) confirmed that Poodle and Schnauzer 
were the predominant breeds of dogs in a four 
year period (2005-2009), in agreement with 
previous reports in which old dogs from similar 
breeds were studied (3,4). This result is in 
contrast with other epidemiological reports (16, 
17) probably as a consequence of the proportion 
of breed predominant in each particular country. 
The average age at the diagnosis of MCMT 
in bitches in our study was at 10.87 years 
in agreement with previous reports (16-18). 
Similarly, in a study carried out in bitches suffering 
of MCMT the range of age varied between 5 
years to 14 years and 10 months old (19). The 
advanced age that was found in this study at the 
time of clinical diagnosis in bitches affected by 
mammary tumors, could be partially explained 
by the habit of small animal practitioners in 
our city to recommend their owners waiting for 
a more advance size of the mammary tumor, 
before practicing a diagnostic procedure (surgical 
biopsy or fine needle aspiration). 
In some cases, the owner’s inadequate care 
of their dogs is responsible for their small 
Figure 6. Simple tubular carcinoma characterized by 
the presence of abundant tubular structures 
(arrowheads). H&E, 200X.
Figure 7. Tubulopapillary carcinoma presenting 
abundant papillary structures directed 
toward the lumen (arrows). H&E. 200X.
Figure 5. Higher magnification of the complex 
carcinoma indicated in figure 4. Epithelial 
cells are observed forming tubular structures 
or solid areas (arrow). Fusiform mioepithelial 
cells distributed in a reticular pattern are 
observed (arrowhead). H&E, 400X.
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mammary gland nodes to develop toward an 
advanced clinical condition of mammary tumors 
before consulting the veterinarian, which causes 
misdiagnosis at early stages of the condition 
in the affected dog. In other cases and due to 
the owner’s negligence, the affected mammary 
glands develop toward a more advanced stage 
of the tumor, including variable grades of clinical 
signs such as inflamed/ulcerated mammary 
glands, even with a critical general compromise 
of the patient. Representative cases of this 
situation have been reported elsewhere (for 
example, see figure 1 in the report by Andrade et 
al, 2010) (7) and figure 6 in the report by Otini et 
al, 2010 (19). Because in dogs there is a normal 
course of mammary tumor progression from a 
benign pattern toward malignancy (18), an early 
diagnosis and treatment of the condition would 
probably avoid the affected bitch to develop 
a malignant form of the neoplasm, and would 
prevent a potential risk of metastases.
The most frequently affected glands in bitches in 
our study were the inguinal mammary glands, 
which is in agreement with previous reports 
(10,20). The growing capability of inguinal 
mammary glands is greater than that of the 
other glands, a fact that could be explained by 
its greater vascular supply and its greater lymph 
drainage. This particular physiological situation 
could support its major compromise in neoplasm 
development and metastasis (20). In the original 
reports by Patsikas and Dessiris (21) the authors 
suggested the existence of lymphatic vessel 
connections between the lymph nodes draining 
both sides of the mammary gland, in which 
most of the connections are established with the 
inguinal lymph nodes. 
The finding of a greater compromise of inguinal 
and popliteal lymph nodes was as expected, 
because these lymph nodes drains the inguinal 
mammary gland, which was found the most 
affected gland in this study, in agreement with 
previous reports in dogs (10,20,22) and cats 
(23), which suggest there are an intricate 
communication between the lymph nodes 
draining the mammary gland. Together with the 
high frequency of compromise of the inguinal 
mammary gland in our study, these results 
explain, at least partially, the most frequent 
compromise of the inguinal lymph nodes in 
bitches affected by MCMT. As we shall see, this 
would be a rational explanation for the incidence 
of lung metastasis in bitches. 
In our study most of the mammary glands 
affected by neoplasm (83.74%) exhibited 
histopathological findings of malignancy, mainly 
carcinoma (81%), and in a lesser percentage 
fibrosarcoma (2.7%), whereas only 8.1% of 
the samples showed benign characteristics 
(adenomas). Our data are in agreement with 
a previous study by Lockett (2005) and with 
retrospective data from our Laboratory, in which 
the frequency of malignant mammary tumors 
was 68.1%, from which 58.6% of tumors were 
diagnosed as carcinoma (9). Similarly, other 
authors found a predominant diagnosis of 
coriocarcinoma in bitches affected by mammary 
tumors (16,18). On the contrary, our data 
are not in agreement with previous reports in 
which predominance of benign (60% to 40%) 
versus malignant (30%-40%) mammary 
tumors was reported, where malignant tumors 
included complex carcinoma, simple carcinoma 
(tubulopapilar, solid, cribiforme and anaplasic, 
and solid carcinoma), and sarcoma (fibrosarcoma, 
osteosarcoma, and carcinosarcoma) (24,25). 
When lung metastases were confirmed on the 
basis of radiographic findings, it was found in 
5 out of 30 (16.6%) bitches in our study. This 
data support the concept that MCMT, mainly 
carcinoma, behaves as a highly invasive and 
metastatic tumor, because of its high growing 
capability and its infiltration potential (8). The 
radiographic diagnosis of lung metastases is 
characterized by a structured interstitial pattern, 
non-cavitary, characterized by the presence 
of multiple nodules of approximately 5-6 mm 
diameter (11), whereas nodules having a lesser 
diameter should be grouped together for being 
visible at radiographic examination. 
The finding of 16.66% frequency of lung 
metastases is lower than a previous study 
where the frequency of metastases reported was 
25% to 50% (4). In the work by Clement et al, 
2010, authors provided evidence that computed 
tomography is a more accurate method than 
radiography for the diagnosis of lung metastases 
(17). For instance, our results on the frequency of 
lung metastases based on radiographic diagnosis 
should be considered cautiously if used for 
comparative purposes. It is important to recall 
that the postsurgical recurrence rate of bitches 
affected by MCMT is up to 58% (26) as well as the 
relationship between prognostic factors (27) and 
type of tumor and survival rate (28,29).
Regarding sample size in our study (n=30 cases 
in 10 months period of study), the results of 
a previous retrospective study performed to 
evaluate the frequency of canine mammary 
tumors in Colombia, in a sample of 173 tumors 
in a 25 year sample period, represented a mean 
frequency  of 7 cases per year (30). In this study 
authors found that 18.73% of the bitches were 
included in the range of age of 120 months, 
2989Gómez - Presence of lung metastases in bitches affected by malignant
comparable with the average age of bitches in our 
study (Table 1). The predominant breed found by 
these authors was Cocker spaniel (23.8%) —this 
finding would probably reflect the predominance 
of this breed during the time period of sampling 
(1975-2000). The second predominant breed 
they found was poodle (30), in agreement with 
our results (Figure 1). 
In the study by Torres and Botero (2008) 
malignancy was reported in 41% of the cases. Mixt 
Malignant Mammary tumor (recently classified 
as carcinosarcoma) was found in 12 out of 32 
(37.5%) cases and simple tubular carcinoma 
was found in 4 out of 32 (12.5%) cases, in the 
group of age greater than 120 months (see table 
4 in reference 30) corresponding to the range 
of age of bitches in our study. Data from this 
report are partially similar with our data in which 
complex carcinoma (43.2%), simple carcinoma 
(13.5%), and tubular carcinoma (8.1%) were 
the predominant type of tumors.
 
Data from the present pilot study do not exclude 
the possibility that dogs were affected by 
other primary tumors or had presented other 
metastatic sites. For that reason, further studies 
in bitches affected by MCMT should include the 
histopathological evaluation of regional lymph 
nodes, and abdominal ultrasound evaluation 
for defining other metastatic sites different to 
lung. Similarly, it would support a more precise 
surgical procedure used for resection of affected 
mammary glands. 
Finally, our data also corroborates the importance 
for establishing a radiographic evaluation 
of female dogs affected by mammary gland 
tumors as a routine practice, due to its valuable 
prognostic value for diagnosis of metastases 
(24). If the veterinarian uses a precise protocol 
on a routinely basis, a great advance on earlier 
detection of MCMT and its metastases should be 
gained, with implications for the clinical evolution 
of the affected patient. Furthermore, the results 
of this study supports the concept that a finding 
of a clinically normal lymph node draining an 
affected mammary gland, do not mean they are 
not histopathologically affected, and suggest 
that sampling the affected lymph node should be 
always considered. 
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